Efficacy of venetoclax based salvage chemotherapy followed by "Minimal Residual Disease driven"-venetoclax maintenance therapy post-allotransplant in a young patient with high risk primary refractory acute myeloid leukemia
published in: Leukemia & Lymphoma
date of publication: 2020-05-02
main subject: acute myeloid leukemia
Cites articles
There is nothing here
Article - wd:Q94505995